S3-E25.5 - Emerging Concepts in NASH: Fatty Liver Pathophysiology, Epidemiology, Co-Morbidities

Send us Fan MailThis conversation is centered on Mazen Noureddin's portion of Madrigal's disease-focused presentation at the Chronic Liver Disease Foundation's LiverConnect meeting this past March in Scottsdale, AZ. Mazen addresses issues of NAFLD Pathophysiology and NASH epidemiology, after which he answers questions and reviews key elements of the presentation with Roger Green.This episode and all its conversations are sponsored by Madrigal Pharmaceuticals. Conversations 25.5 and 25.6 are a two-part summary of Madrigal's disease-focused presentation at the recent CLDF LiverConnect meeting.